Symbiotec IPO Allotment Status: Live GMP Today & Allotment Chances

The Symbiotec Pharmalab IPO allotment status will be available on Friday, August 28, 2026. Investors can check their allotment status online through the IPOwiz App, MUFG Intime India Website, BSE, or via their demat/bank account. Below is a complete step-by-step guide to help you check your allotment status, latest GMP, final subscription numbers, and allotment chances:

Latest Grey Market Premium (GMP)

The grey market premium shows how investors feel about the IPO before listing. Here's how Symbiotec Pharmalab GMP has changed:

Join us on Telegram for live IPO updates: Click Here

Final Subscription in Symbiotec Pharmalab:

Allotment Chances in Symbiotec Pharmalab:

How to Check Symbiotec Pharmalab IPO Allotment Status

Symbiotec Pharmalab IPO allotment status will be available on Friday, August 28, 2026. Here's how you can check:

Option 1: Via IPOwiz App

1. Download the IPOwiz App from the Play Store or App Store.
2. Add the PAN numbers you want to check in the PAN section.
3. Go to the Allotted Section and select Symbiotec Pharmalab IPO.
4. View the allotment status for the saved PAN numbers.

Option 2: Via MUFG Intime India Website

1. Visit the MUFG Intime India IPO Allotment Page.
2. Select Symbiotec Pharmalab Limited from the drop-down menu.
3. Enter your PAN number, application number, or demat account details.
4. Click Search to view your allotment status.

Option 3: Via BSE Website

1. Go to the official BSE IPO Allotment Page.
2. Choose Issue Type as Equity and select Symbiotec Pharmalab Limited from the list.
3. Enter your PAN number or Application Number.
4. Click Search to check your status.

Option 4: Via Demat Account

• Log in to your demat or trading account (Zerodha, Groww, Angel One, Upstox, etc.).
• Navigate to your portfolio/holdings section from August 29, 2026 onwards. If allotted, the shares will be credited and visible.

Option 5: Via Bank Account

• Log in to the bank account used for the IPO application.
• Check if the blocked amount is debited (allotted) or unblocked/released (not allotted).

Symbiotec Pharmalab IPO Key Dates

• IPO Open Date: August 24, 2026
• IPO Close Date: August 27, 2026
• Allotment Date: August 28, 2026
• Refund Date: August 29, 2026
• Demat Credit Date: August 29, 2026
• Listing Date: September 01, 2026

About Symbiotec Pharmalab

Symbiotec Pharmalab Limited (incorporated in 2002) is an established research-driven pharmaceutical and biotechnology company specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), particularly corticosteroids and steroidal-hormone APIs, alongside contract development and manufacturing (CDMO) services and complex injectables. The company operates industrial-scale manufacturing facilities at Rau and Pithampur SEZ in Madhya Pradesh with US FDA, EU-GMP, and WHO-GMP approvals, alongside newly commissioned biomanufacturing facilities in Ujjain and dedicated complex injectables facilities in Mhow. As of March 31, 2026, Symbiotec served over 200 customers across more than 40 countries, holding 43 US FDA Drug Master Files (DMFs) and 23 European Certificates of Suitability (CEPs).

FAQs

1. When will the Symbiotec Pharmalab IPO allotment be out?
Symbiotec Pharmalab IPO allotment will be available on August 28, 2026.

2. How to check Symbiotec Pharmalab IPO allotment status online?
You can check the allotment via IPOwiz App, MUFG Intime India website, BSE, or your demat account.

3. What is the expected listing price of Symbiotec Pharmalab IPO?
Based on ₹270.00 GMP, the expected listing price is ₹1,258 (27.33% above IPO price of ₹988).

4. What are the allotment chances for retail investors?
Retail investors have roughly a 1 out of 12 chance (~8.5% per application).

5. When will shares be credited to demat accounts?
Shares will be credited by August 29, 2026 for successful allotments.

6. When is Symbiotec Pharmalab IPO listing date?
The shares will list on BSE and NSE on September 01, 2026.

7. Can I sell shares on listing day?
Yes, you can sell allotted shares when trading begins on September 01.

8. Is Symbiotec Pharmalab IPO good for long-term?
The GMP indicates a strong listing gain. Backed by global leadership in steroidal APIs, US FDA-approved facilities, and a diversified export client base, long-term investors can evaluate post-listing performance and financial growth.

For further queries contact the IPO registrar, MUFG Intime India.